Dalen Meeter - 15 Sep 2024 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Financial Officer
Signature
/s/ Dalen Meeter
Issuer symbol
N/A
Transactions as of
15 Sep 2024
Net transactions value
$0
Form type
4
Filing time
17 Sep 2024, 19:36:34 UTC
Previous filing
13 Aug 2024
Next filing
13 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +209 +2.6% 8,193 15 Sep 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -209 -9.1% 2,083 15 Sep 2024 Common Stock 209 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.